CALEY BAGGETT: Open Payments
NPI 1225471725 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,144 in 68 payments from 16 companies in 2025. Trend: 2023 $1,126 · 2024 $1,367 · 2025 $1,144
Food & beverage: $1,144
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 11 | $198 |
| Novo Nordisk Inc | 11 | $193 |
| ABBVIE INC. | 12 | $141 |
| Lilly USA, LLC | 8 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $90 |
| Abbott Laboratories | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $54 |
| GlaxoSmithKline, LLC. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $34 |
Products named: NURTEC ODT, Ozempic, QULIPTA, Kerendia, FREESTYLE LIBRE 3, Wegovy, ELIQUIS, MOUNJARO.
Industry payments across AL — which companies pay providers there.
